1. Home
  2. PSNL vs CKPT Comparison

PSNL vs CKPT Comparison

Compare PSNL & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • CKPT
  • Stock Information
  • Founded
  • PSNL 2011
  • CKPT 2014
  • Country
  • PSNL United States
  • CKPT United States
  • Employees
  • PSNL N/A
  • CKPT N/A
  • Industry
  • PSNL Medical Specialities
  • CKPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PSNL Health Care
  • CKPT Health Care
  • Exchange
  • PSNL Nasdaq
  • CKPT Nasdaq
  • Market Cap
  • PSNL 321.1M
  • CKPT N/A
  • IPO Year
  • PSNL 2019
  • CKPT 2017
  • Fundamental
  • Price
  • PSNL $5.19
  • CKPT $3.77
  • Analyst Decision
  • PSNL Strong Buy
  • CKPT Strong Buy
  • Analyst Count
  • PSNL 4
  • CKPT 2
  • Target Price
  • PSNL $6.81
  • CKPT $12.00
  • AVG Volume (30 Days)
  • PSNL 439.4K
  • CKPT 946.5K
  • Earning Date
  • PSNL 11-06-2024
  • CKPT 11-11-2024
  • Dividend Yield
  • PSNL N/A
  • CKPT N/A
  • EPS Growth
  • PSNL N/A
  • CKPT N/A
  • EPS
  • PSNL N/A
  • CKPT N/A
  • Revenue
  • PSNL $80,027,000.00
  • CKPT $78,000.00
  • Revenue This Year
  • PSNL $10.85
  • CKPT N/A
  • Revenue Next Year
  • PSNL $8.77
  • CKPT $151,162.55
  • P/E Ratio
  • PSNL N/A
  • CKPT N/A
  • Revenue Growth
  • PSNL 19.20
  • CKPT N/A
  • 52 Week Low
  • PSNL $0.89
  • CKPT $1.36
  • 52 Week High
  • PSNL $7.20
  • CKPT $3.95
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 56.29
  • CKPT 84.67
  • Support Level
  • PSNL $4.54
  • CKPT $2.37
  • Resistance Level
  • PSNL $5.35
  • CKPT $2.54
  • Average True Range (ATR)
  • PSNL 0.30
  • CKPT 0.27
  • MACD
  • PSNL 0.05
  • CKPT 0.10
  • Stochastic Oscillator
  • PSNL 84.71
  • CKPT 88.60

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: